发明名称 Oligonucleotide modulation of cell adhesion
摘要 Compositions and methods are provided for the treatment and diagnosis of diseases amenable to treatment through modulation of the synthesis or metabolism of intercellular adhesion molecules. In accordance with preferred embodiments, oligonucleotides are provided which are specifically hybridizable with nucleic acids encoding intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and endothelial leukocyte adhesion molecule-1. The oligonucleotide comprises nucleotide units sufficient in identity and number to effect said specific hybridization. In other preferred embodiments, the oligonucleotides are specifically hybridizable with a transcription initiation site, a translation initiation site, 5'-untranslated sequences, 3'-untranslated sequences, and intervening sequences. Methods of treating animals suffering from disease amenable to therapeutic intervention by modulating cell adhesion proteins with an oligonucleotide specifically hybridizable with RNA or DNA corresponding to one of the foregoing proteins are disclosed. Methods for treatment of diseases responding to modulation cell adhesion molecules are disclosed.
申请公布号 AU4840193(A) 申请公布日期 1994.03.29
申请号 AU19930048401 申请日期 1993.08.27
申请人 ISIS PHARMACEUTICALS INC 发明人 BENNET C FRANK;MIRABELLI CHRISTOPHER K
分类号 C12N15/09;A61K31/00;A61K31/70;A61K31/7088;A61K38/00;A61K48/00;A61P17/00;A61P17/06;A61P25/04;A61P29/00;A61P35/00;A61P35/04;C07H21/02;C07H21/04;C07K14/705;C12N15/113;C12Q1/68 主分类号 C12N15/09
代理机构 代理人
主权项
地址